Reversal of hypothermia induced action potential lengthening by the K(ATP) channel agonist bimakalim in isolated guinea pig ventricular muscle

General Pharmacology

Volumn 31, Issue 1, 1998, Pages 125-131

  Lathrop, David A ^a   Contney, Stephen J ^a   Bosnjak, Zeljko J ^a   Stowe, David F ^a  

^a Department of Anesthesiology   (United States)

Author keywords

Action potential duration; ATP sensitive K+ channel openers; Bimakalim; Diastolic membrane potential; Glibenclamide; Guinea pig; Hypothermia; Ventricular muscle

Indexed keywords

BIMAKALIM; GLIBENCLAMIDE; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; GUINEA PIG; HEART VENTRICLE WALL; HYPOTHERMIA; MEMBRANE POTENTIAL; MUSCLE ACTION POTENTIAL; NONHUMAN; PRIORITY JOURNAL;

EID: 0032127418     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(97)00395-9     Document Type: Article

References (61)

1. Allen D.G., Cairns S.P., Turvey S.E., Lee J.A. Intracellular calcium and myocardial function during ischemia. Adv. Exp. Med. Biol. 346:1993;19-29.
2. Auchampach J.A., Gross G.J. Anti-ischemic actions of potassium channel openers in experimental myocardial ischemia/reperfusion injury in dogs. Eur. Heart. J. 14(suppl. B):1993;10-15.
3. Auchampach J.A., Gross G.J. Reduction in myocardial infarct size by the new potassium channel opener bimakalim. J. Cardiovasc. Pharmacol. 23:1994;554-561.
4. Auchampach J.A., Maruyama M., Gross G.J. Cardioprotective actions of potassium channel openers. Eur. Heart J. 15(suppl. C):1994;89-94.
5. ATP-channel openers protect against increased cytosolic calcium during ischemia and reperfusion. J. Mol. Cell. Cardiol. 27:1995;1809-1817.
6. Bers D.M. Species differences and the role of sodium-calcium exchange in cardiac muscle relaxation. Ann. NY Acad. Sci. 639:1991;375-385.
7. 2+ transients during rapid cooling contractures in guinea-pig ventricular myocytes. J. Physiol. 417:1989;537-553.
8. Bjørnstad H., Lathrop D.A., Refsum H. Prevention of some hypothermia induced electromechanical changes by calcium channel blockade. Cardiovasc. Res. 28:1994;55-60.
9. Black S.C., Lucchesi B.R. Potassium channel openers are likely to be proarrhythmic in the diseased human heart. Cardiovasc. Res. 28:1994;923-924.
10. Boban M., Stowe D.F., Gross G.J., Pieper G.M., Kampine J.P., Bosnjak Z.J. Potassium channel openers attenuate atrioventricular block by bupivacaine in isolated hearts. Anesth. Analg. 76:1993;1259-1265.
11. +-channel openers. J. Cardiovasc. Pharmacol. 20(suppl. 3):1992;S13-S16.
12. Carlsson L., Abrahamsson C., Drews L., Duker G. Antiarrhythmic effects of potassium channel openers in rhythm abnormalities related to delayed repolarization. Circulation. 85:1992;1491-1500.
13. Cave A.C., Hearse D.J. Ischemic preconditioning and contractile function. studies with normothermic and hypothermic global ischaemia J. Mol. Cell. Cardiol. 24:1992;1113-1123.
14. + ATP channel blockade on interstitial adenosine accumulation in ischemic rabbit myocardium. Basic Res. Cardiol. 90:1995;410-417.
15. + channels in cardiac ischemia. an endogenous mechanism for protection of the heart Cardiovasc. Drugs Ther. 7(suppl. 3):1993;527-537.
16. + channels protect the myocardium against ischemia/reperfusion damage. Circ. Res. 69:1991;571-581.
17. D'Alonzo A.J., Grover G.J. Potassium channel openers are unlikely to be proarrhythmic in the diseased human heart. Cardiovasc. Res. 28:1994;924-925.
18. DeLean A., Munson P.J., Rodbard D. Simultaneous analysis of families of sigmoidal curves. application to bioassay, radioligand assay and physiologic dose response curves Am. J. Physiol. 235:1978;E97-E102.
19. Fralix T.A., Steenbergen C., London R.E., Murphy E. Glibenclamide does not abolish the protective effect of preconditioning on stunning in the isolated perfused rat heart. Cardiovasc. Res. 27:1993;630-673.
20. Fukumoto K., Takenaka H., Koga Y., Hamada M. Effect of prolonged hypothermic ischemia on myocardial sarcoplasmic reticular calcium transport. Cardiovasc. Res. 24:1990;169-175.
21. Gross G.J. ATP-sensitive potassium channels and myocardial preconditioning. Basic Res. Cardiol. 90:1995;85-88.
22. Gross G.J., Auchampach J.A., Maruyama M., Warltier D.C., Pieper G.M. Cardioprotective effects of nicorandil. J. Cardiovasc. Pharmacol. 20(suppl. 3):1992;S22-S28.
23. ATP channels meet the requirements? Basic Res. Cardiol. 91:1996;31-34.
24. ATP openers in ischemic rat hearts treated with a potassium cardioplegic solution. J. Cardiovasc. Pharmacol. 26:1995;698-706.
25. Grover G.J., Dzwonczyk S., Sleph P.G., Sargent C.A. The ATP-sensitive potassium channel blocker glibenclamide (glyburide) does not abolish preconditioning in isolated ischemic rat hearts. J. Pharmacol. Exp. Ther. 265:1993;559-564.
26. ATP opener cromakalim is not correlated with ischemic myocardial action potential duration. J. Cardiovasc. Pharmacol. 26:1995;145-152.
27. 1 receptors in ischemic rat hearts. Cardiovasc. Res. 31:1996;511-517.
28. Henden T., Larsen T.S., Lathrop D.A. Effect of stimulation and veratrine on total cellular calcium in rat and guinea-pig ventricular myocytes. Basic Res. Cardiol. 88:1993;557-565.
29. 2+ window current in heart cells. Circ. Res. 70:1992;445-455.
30. Kneer S.M., Lieberman M. Ion transport during hypothermia in cultured heart cells. implications for protection of the immature myocardium J. Mol. Cell. Cardiol. 25:1993;277-288.
31. Kiyosue T., Arita M., Muramatsu H., Spindler A.J., Noble D. Ionic mechanisms of action potential prolongation at low temperature in guinea-pig ventricular myocytes. J. Physiol. 468:1993;85-106.
32. Lathrop D.A., Nànàsi P.P., Varrò A. In vitro cardiac models of dog Purkinje fibre triggered and spontaneous electrical activity. effects of nicorandil Br. J. Pharmacol. 99:1990;119-123.
33. Lawton J.S., Harrington G.C., Allen C.T., Hsia P.W., Damiano R.J. Jr. Myocardial protection with pinacidil cardioplegia in the blood-perfused heart. Ann. Thor. Surg. 61:1996;1680-1688. a.
34. Lawton J.S., Sepic J.D., Allen C.T., Hsia P.W., Damiano R.J. Jr. Myocardial protection with potassium-channel openers is as effective as St. Thomas' solution in the rabbit heart. Ann. Thor. Surg. 62:1996;31-38. b.
35. 2+ in rat ventricular myocytes. Cell Calcium. 12:1991;11-18.
36. McCully J.D., Tsukube T., Ataka K., Krukenkamp I.B., Feinberg H., Levitsky S. Myocardial cystolic calcium accumulation during ischemia/reperfussion. the effects of aging and cardioplegia J. Cardiac. Surg. 9(suppl. 3: 449-452):1994.
37. Menasche P., Mousas C., Grousset C. Is potassium channel opening an effective form of preconditioning before cardioplegia? Ann. Thor. Surg. 61:1996;1764-1768.
38. Mizumura T., Nithipatikom K., Gross G.J. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs. Circulation. 92:1995;1236-1245.
39. 2so) and storage at -196°C. Cryobiology. 31:1994;330-335.
40. Olschewski A., Brau M.E., Olshewski H., Hempelmann G., Vogel W. ATP-dependent potassium channel in rat cardiomyocytes is blocked by lidocaine. Possible impact on the antiarrhythmic action of lidocaine. Circulation. 93:1996;656-659.
41. 2+ and contraction in isolated hearts. FASEB J. 11:1997;A526.
42. Pytowski B., Lewartowski B., Prokopczuk A., Zdanowski K., Lewandowska K. Excitation- and rest-dependent shifts of Ca in guinea-pig ventricular myocardium. Pflugers Arch. 398:1983;103-113.
43. Quast U. Potassium channel openers. pharmacological and clinical aspects Fund. Clin. Pharmacol. 6:1992;279-293.
44. Robinson L.A., Harwood D.L. Lowering the calcium concentration in St. Thomas' Hospital cardioplegic solution improves protection during hypothermic ischemia. J. Thorac. Cardiovasc. Surg. 101:1991;314-325.
45. Rohmann S., Weygandt H., Schelling P., Kie Soei L., Verdouw P.D., Lues I. Involvement of ATP-sensitive potassium channels in preconditioning protection. Basic Res. Cardiol. 89:1994;563-576.
46. Schilling A., Glusa E., Muller-Schweinitzer E. Nature of the vehicle solution for cryopreservation of human peripheral veins. preservation of reactivity to pharmacological stimuli Cryobiology. 32:1995;109-113.
47. + activities and resting membrane potential in sheep cardiac Purkinje strands. Circ. Res. 47:1980;692-700.
48. Sprung J., Stowe D.F., Kampine J.P., Bosnjak Z.J. Mild hypothermia alters effects of halothane and isoflurane on contractile force and calcium transients of cardiac Purkinje fibers. Am. J. Physiol. 267:1994;H725-H733.
49. Stowe D.F. Excitation-contraction uncoupling and vasodilators for long-term cold preservation of isolated hearts. Adv. Pharmacol. 31:1994;39-61.
50. Stowe D.F., Boban M., Graf B.M., Bosnjak Z.J., Kampine J.P. Contraction uncoupling vs. low calcium or high potassium for long-term cold preservation of isolated hearts. Circulation. 89:1994;2412-2420.
51. Stowe D.F., Graf B.M., Fujita S., Gross G.J. One-day cold perfusion of bimakalim and butanedione monoxime restores ex situ cardiac function. Am. J. Physiol. 27(1):1996;H1884-H1892.
52. Toombs C.F., Moore T.L., Shebuski R.J. Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide. Cardiovasc. Res. 27:1993;617-622.
53. Tosaki A., Szerdahelyi P., Engleman R.M., Das D.K. Potassium channel openers and blockers. do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts? J. Pharmacol. Exp. Ther. 267:1993;1355-1362.
54. ATP channel. Am. J. Physiol. 266:1994;H829-H839.
55. Van Woerkens L.J., Baas N.R., van der Giessen W.J., Verdouw P.D. Cardiovascular effects of a novel potassium channel opener bimakalim in conscious pigs after myocardial infarction. a comparative study with nicorandil Cardiovasc. Drugs Ther. 6:1992;409-417.
56. Vegh A., Papp J.G., Szekeres L., Parratt J.R. Are ATP sensitive potassium channels involved in the pronounced antiarrhythmic effects of preconditioning? Cardiovasc. Res. 27:1993;638-643.
57. + ATP-channel opening and arrhythmogenesis. J. Cardiovasc. Pharmacol. 24(suppl. 4):1994;S35-S40.
58. Yanagisawa T., Taira N. Effect of 2-nicotinamidethyl nitrate (Sg-75) on membrane potentials of canine Purkinje fibers. Jpn. J. Pharmacol. 31:1981;409-417.
59. Yang T., Tande P.M., Lathrop D.A., Refsum H. Class III antiarrhythmic action by potassium channel blockade. dofetilide attenuates hypoxia induced electromechanical changes Cardiovasc. Res. 26:1992;1109-1115.
60. Yao Z., Gross G.J. Activation of ATP-sensitive potassium channels lowers threshold for ischemic preconditioning in dogs. Am. J. Physiol. 267:1994;H1888-H1894. a.
61. ATP channel opener bimakalim on coronary blood flow monophasic action potential duration, and infarct size in dogs. Circulation. 89:1994;1769-1775. b.